{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:19:18Z","timestamp":1787167158353,"version":"build-2736575974"},"reference-count":21,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"GlaxoSmithKline (GSK) Research and Development"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.4155\/bio.10.105","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T13:26:40Z","timestamp":1282138000000},"page":"1515-1522","source":"Crossref","is-referenced-by-count":43,"title":["Use of DBS Sample Collection to Determine Circulating Drug Concentrations in Clinical Trials: Practicalities and Considerations"],"prefix":"10.1080","volume":"2","author":[{"given":"Neil","family":"Spooner","sequence":"first","affiliation":[{"name":"Platform Technologies and Science Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, SG12 0DP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ramakrishnan","sequence":"additional","affiliation":[{"name":"Addenbrooke\u2019s Center for Clinical Investigation, GlaxoSmithKline Research and Development, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Barfield","sequence":"additional","affiliation":[{"name":"Platform Technologies and Science Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, SG12 0DP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Dewit","sequence":"additional","affiliation":[{"name":"Addenbrooke\u2019s Center for Clinical Investigation, GlaxoSmithKline Research and Development, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Miller","sequence":"additional","affiliation":[{"name":"Discovery Analytics, GlaxoSmithKline Research and Development, Hills Road, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,8,18]]},"reference":[{"key":"e_1_3_5_3_1_1","unstructured":"Toxicokinetics: the assessment of systemic exposure in toxicity studies. ICH Harmonised Tripartate Guideline S3A (1995)."},{"key":"e_1_3_5_3_2_1","unstructured":"The common technical document for the registration of pharmaceuticals for human use. ICH Common Technical Document M4 (1999)."},{"key":"e_1_3_5_3_3_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.32.3.338"},{"key":"e_1_3_5_3_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31819e91ce"},{"key":"e_1_3_5_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2006.09.036"},{"key":"e_1_3_5_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1367"},{"key":"e_1_3_5_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.05.025"},{"key":"e_1_3_5_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00607678"},{"key":"e_1_3_5_3_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007669411738"},{"key":"e_1_3_5_3_10_1","unstructured":"US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM): Guidance for industry: bioanalytical method validation. Federal Register (2001)."},{"key":"e_1_3_5_3_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac8022839"},{"key":"e_1_3_5_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90837-8"},{"key":"e_1_3_5_3_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/096228029900800204"},{"key":"e_1_3_5_3_14_1","volume-title":"British Journal Pharmacology Winter Meeting.","author":"Mohammed BA","year":"2008","unstructured":"Mohammed BA , MohamedIN, CameronGA, HawksworthGM, HelmsPJ, McLayJS. The use of finger-prick rather than venous blood samples to determine the pharmacokinetics of paracetamol. Presented at:British Journal Pharmacology Winter Meeting. Brighton, UK, 18 December (2008)."},{"key":"e_1_3_5_3_15_1","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2008.008147"},{"key":"e_1_3_5_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200010000-00015"},{"key":"e_1_3_5_3_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198917030-00004"},{"key":"e_1_3_5_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2009.02.001"},{"key":"e_1_3_5_3_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac901985e"},{"key":"e_1_3_5_4_2_1","unstructured":"Knudsen RC Slazyk WE Richmond JY Hannon WH. Guidelines for the shipment of dried blood spot specimens. Centers for Disease Control and Prevention www.cdc.gov\/od\/ohs\/biosfty\/driblood.htm"},{"key":"e_1_3_5_4_3_1","unstructured":"Whatman FTA\u00ae DMPK cards www.whatman.com\/DMPK.aspx (Accessed on 12March2010)"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio.10.105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:32:54Z","timestamp":1715959974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio.10.105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.4155\/bio.10.105"],"URL":"https:\/\/doi.org\/10.4155\/bio.10.105","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}